Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masaad Almutairi"'
Autor:
Nawaf Masaad Almutairi, Faisal Mohammed Hilal, Ahmed Bashawyah, Fatma Al Dammas, Ece Yamak Altinpulluk, Jin-De Hou, Jui-An Lin, Giustino Varrassi, Ke-Vin Chang, Abdallah El-Sayed Allam
Publikováno v:
Healthcare, Vol 10, Iss 7, p 1176 (2022)
Introduction: This network meta-analysis aimed to assess the efficacy of acupuncture, intravenous lidocaine, and diet compared with other comparators such as physiotherapy and sham/placebo in fibromyalgia patients. Materials and Methods: We searched
Externí odkaz:
https://doaj.org/article/a8f236f151664ad68b8845b80daa1be3
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 10; Pages: 2818
The outbreak and continuing impact of COVID-19 have significantly increased the rates of hospitalization and admissions to intensive care units (ICU). This study evaluates clinical outcomes in critically ill patients and investigates variables tied t
Autor:
Saad Fallatah, Faris S Alnezary, Anne J Gonzales-Luna, Kevin W. Garey, Khurshida Begum, M. Jahangir Alam, Masaad Almutairi
Publikováno v:
Anaerobe
BACKGROUND: Although Clostridioides difficile surveillance often identifies emerging strains, clinical outcome evaluations are rarely performed. Ribotype (RT) 106 is a commonly isolated C. difficile strain worldwide; however, studies investigating RT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1733fcf0398ca7dd900ac90c7b86fb
https://europepmc.org/articles/PMC8678208/
https://europepmc.org/articles/PMC8678208/
Autor:
Khurshida Begum, Saad Fallatah, Anne J Gonzales-Luna, Faris S Alnezary, M. Jahangir Alam, Kevin W. Garey, Masaad Almutairi
Publikováno v:
Open Forum Infectious Diseases
Background Clostridioides difficile ribotype (RT) 106 has emerged as one of the most commonly isolated strains in the USA and worldwide. However, studies investigating clinical outcomes associated with this strain are lacking. The purpose of this stu
Publikováno v:
Open Forum Infectious Diseases
Background Proton pump inhibitors (PPI) display pleotropic properties that increase the risk of poor outcomes in patients with C. difficile infection (CDI). However, clinical data on PPI and CDI outcomes is controversial perhaps due to lack of knowle
Autor:
Masaad Almutairi, Anne J Gonzales-Luna, Khurshida Begum, Saad Fallatah, Faris S Alnezary, Kevin W. Garey, M. Jahangir Alam
Publikováno v:
Open Forum Infectious Diseases
Background Ursodeoxycholic acid (UDCA), a secondary bile acid, inhibits germination and growth of Clostridioides difficile in vitro, but the results from in vivo experiments have been conflicting. We evaluated the effects of UDCA on C. difficile in v